Decrease in P-selectin levels in patients with hypercholesterolaemia and peripheral arterial occlusive disease after lipid-lowering treatment

Vascular Medicine

Volumn 4, Issue 1, 1999, Pages 23-26

  Kirk, Gwen ^a   McLaren, Margaret ^a   Muir, Andrew H ^a   Stonebridge, Peter A ^a   Belch, Jill J F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Atherosclerosis; Cholesterol; Endothelium; Peripheral arterial occlusive disease; Platelets

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; FLUINDOSTATIN; PADGEM PROTEIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; BLOOD VESSEL INJURY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032921410     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358836x9900400104     Document Type: Article

References (23)

1. Calderon TM, Factor SM, Hatcher VB, Berliner JA, Berman JW. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Lab Invest 1994; 70(6): 836-49.
2. Faruqi RM, DiCorleto PE. Mechanisms of monocyte recruitment and accumulation. Br Heart J 1993; 69: S19-S29.
3. Numano F, Kishi Y, Ashikaga T, Hata A, Makita T, Watanabe R. What effect does controlling platelets have on atherosclerosis? Ann N Y Acad Sci 1995; 748: 383-92.
4. Holvoet P, Collen D. Thrombosis and atherosclerosis. Curr Opin Lipidol 1997; 8(5): 320-28.
5. Cronstein BN, Weissman G. The adhesion molecules of inflammation. Arthrit Rheum 1993; 36(2): 147-57.
6. Yeo EL, Sheppard JL, Feuerstein IA. Role of P-selectin and leucocyte activation in polymorphonuclear cell adhesion to surface adherent activated under physiological conditions (an injury vessel wall model). Blood 1994; 83(9): 2498-507.
7. Lawrence MB, Springer TA. Leukocytes roll on E-selectin. J Immunol 1991; 151(11): 6338-46.
8. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 11: 767-804.
9. Webb AT, Franks PJ, Reaveley DA, Greenhalgh RM, Brown EA. Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Eur J Vasc Surg 1993; 7(5): 523-27.
10. Kirk G. Cell adhesion molecules: levels, roles and interactions [PhD Thesis]. Dundee: University of Dundee, 1997.
11. Blann AD, Seigneur M, Boisseau MR, Taberner DA, McCollum CN. Soluble P-selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factors. Blood Coagul Fibrinolysis 1996; 7(8): 789-93.
12. Kirk G, Maple C, McLaren M, Belch JJF. A circadian rhythm may exist in healthy controls for soluble P-selectin and platelet count. Platelets 1995; 6: 414-15.
13. Kirk G, McLaren M, Belch JJF. Soluble P-selectin assay: importance of correct anticoagulant choice. Platelets 1997; 8: 159-62.
14. MRFIT. The Multiple Risk Factor Intervention Trial Research Group. Mortality after 16 years for participants randomised to the Multiple Risk Factor Intervention Trial. Circulation 1996; 94(5): 946-51.
15. Davi G, Romano M. Mezzetti A et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998; 97(10): 953-57.
16. Packman MA, Kinlough-Rathbone RL. Mechanisms of atherogenesis and thrombosis. In: Bloom AL, Forbes CD, Thomas DP, eds. Haemostasis and thrombosis. Volume 2. London: Churchill Livingstone, 1994: 1107-52.
17. Rang HP, Dale MM, Ritter JM. Pharmacology. Edinburgh: Churchill Livingstone, 1995.
18. Furie B, Furie BC. Leukocyte crosstalk at the vascular wall. Thromb Haemost 1997; 78(1): 306-309.
19. Vora DK, Fang ZT, Liva SM et al. Induction of P-selectin by oxidised lipoproteins. Separate effects on synthesis and surface expression. Circ Res 1997; 80(6): 810-18.
20. Betteridge DJ. Diet and drug treatment of the hyperlipidaemias. Risk 1993; 1(3): 25-28.
21. Blann AD, Lip GY, Beevers DG, McCollum CN. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997; 77(6): 1077-80.
22. Bo M, Bonino F, Neirotto M et al. Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs. Angiology 1991; 42(2): 106-13.
23. Osamah H, Mira R, Sorina S, Shlomo K, Michael A. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br J Clin Pharmacol 1997; 44(1): 77-83.